PT Tempo Scan Pacific Tbk Logo

PT Tempo Scan Pacific Tbk

TSPC.JK

(3.5)
Stock Price

2.570 IDR

10.8% ROA

16.48% ROE

9.02x PER

Market Cap.

11.770.734.600.000 IDR

10.59% DER

4.79% Yield

9.74% NPM

PT Tempo Scan Pacific Tbk Stock Analysis

PT Tempo Scan Pacific Tbk Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

PT Tempo Scan Pacific Tbk Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (18.75%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a minimal amount of debt (14%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

5 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

6 PBV

The stock's PBV ratio (1.04x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

8 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

9 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (19.235) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

PT Tempo Scan Pacific Tbk Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

PT Tempo Scan Pacific Tbk Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

PT Tempo Scan Pacific Tbk Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

PT Tempo Scan Pacific Tbk Revenue
Year Revenue Growth
2005 2.497.974.268.976
2006 2.729.223.518.328 8.47%
2007 3.124.072.589.811 12.64%
2008 3.633.789.178.647 14.03%
2009 4.497.931.021.113 19.21%
2010 5.134.242.102.154 12.39%
2011 5.780.664.117.037 11.18%
2012 6.630.809.553.343 12.82%
2013 6.854.889.233.121 3.27%
2014 7.512.115.037.587 8.75%
2015 8.181.481.867.179 8.18%
2016 9.138.238.993.842 10.47%
2017 9.565.462.045.199 4.47%
2018 10.088.118.830.780 5.18%
2019 10.993.842.057.747 8.24%
2020 10.968.402.090.246 -0.23%
2021 11.234.443.003.639 2.37%
2022 12.254.369.318.120 8.32%
2023 13.119.140.249.136 6.59%
2023 13.119.784.555.987 0%
2024 13.341.005.464.840 1.66%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

PT Tempo Scan Pacific Tbk Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 717.350.890 100%
2013 1.276.755.405 43.81%
2014 2.221.281.884 42.52%
2015 9.820.329.977 77.38%
2016 6.804.788.360 -44.31%
2017 4.282.162.613 -58.91%
2018 4.903.077.043 12.66%
2019 4.302.736.164 -13.95%
2020 4.014.197.320 -7.19%
2021 3.878.157.087 -3.51%
2022 4.649.378.196 16.59%
2023 1.857.599.744 -150.29%
2023 2.407.195.862 22.83%
2024 5.872.765.584 59.01%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

PT Tempo Scan Pacific Tbk General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 138.660.847.597
2006 155.711.700.106 10.95%
2007 193.777.669.994 19.64%
2008 209.078.861.508 7.32%
2009 235.168.767.131 11.09%
2010 248.766.455.282 5.47%
2011 297.978.787.115 16.52%
2012 379.484.799.071 21.48%
2013 100.480.998.934 -277.67%
2014 102.491.839.289 1.96%
2015 123.424.113.617 16.96%
2016 137.231.742.368 10.06%
2017 141.710.226.563 3.16%
2018 148.304.074.350 4.45%
2019 158.562.302.029 6.47%
2020 160.960.856.981 1.49%
2021 161.188.523.357 0.14%
2022 169.995.313.151 5.18%
2023 154.163.065.496 -10.27%
2023 178.585.467.736 13.68%
2024 188.851.156.168 5.44%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

PT Tempo Scan Pacific Tbk EBITDA
Year EBITDA Growth
2005 349.359.701.146
2006 312.217.019.026 -11.9%
2007 317.928.520.607 1.8%
2008 362.241.985.904 12.23%
2009 439.359.522.316 17.55%
2010 597.349.847.891 26.45%
2011 662.818.840.982 9.88%
2012 860.697.386.814 22.99%
2013 911.761.717.947 5.6%
2014 841.384.948.260 -8.36%
2015 868.519.245.564 3.12%
2016 878.134.105.808 1.09%
2017 829.897.779.612 -5.81%
2018 903.620.615.570 8.16%
2019 1.007.801.954.048 10.34%
2020 1.323.425.500.186 23.85%
2021 1.364.329.481.325 3%
2022 956.321.888.132 -42.66%
2023 1.896.358.987.548 49.57%
2023 1.571.187.648.380 -20.7%
2024 2.328.007.553.960 32.51%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

PT Tempo Scan Pacific Tbk Gross Profit
Year Gross Profit Growth
2005 1.084.818.502.900
2006 1.118.927.381.243 3.05%
2007 1.279.594.265.677 12.56%
2008 1.414.544.400.877 9.54%
2009 1.675.579.434.766 15.58%
2010 1.894.330.075.143 11.55%
2011 2.200.042.756.418 13.9%
2012 2.488.320.692.802 11.59%
2013 2.719.802.668.112 8.51%
2014 2.939.896.636.583 7.49%
2015 3.117.572.215.514 5.7%
2016 3.484.364.171.176 10.53%
2017 3.658.175.142.200 4.75%
2018 3.841.582.210.698 4.77%
2019 4.241.529.318.712 9.43%
2020 3.912.789.079.505 -8.4%
2021 4.008.293.389.897 2.38%
2022 4.164.561.467.956 3.75%
2023 4.793.504.656.616 13.12%
2023 4.513.760.244.824 -6.2%
2024 4.803.234.525.008 6.03%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

PT Tempo Scan Pacific Tbk Net Profit
Year Net Profit Growth
2005 296.824.571.606
2006 272.583.806.584 -8.89%
2007 278.357.723.400 2.07%
2008 320.647.898.367 13.19%
2009 359.964.376.338 10.92%
2010 488.889.258.921 26.37%
2011 566.048.397.448 13.63%
2012 627.950.145.504 9.86%
2013 634.622.746.467 1.05%
2014 579.379.534.765 -9.53%
2015 521.959.194.423 -11%
2016 536.273.826.937 2.67%
2017 543.803.896.478 1.38%
2018 512.028.758.825 -6.21%
2019 554.263.001.029 7.62%
2020 787.803.135.441 29.64%
2021 823.767.936.791 4.37%
2022 1.001.627.721.850 17.76%
2023 1.037.351.142.308 3.44%
2023 1.177.431.714.478 11.9%
2024 1.654.450.896.460 28.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

PT Tempo Scan Pacific Tbk Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 66
2006 61 -8.2%
2007 62 1.61%
2008 71 12.68%
2009 80 11.25%
2010 109 26.61%
2011 126 13.49%
2012 140 10%
2013 141 0.71%
2014 129 -9.3%
2015 116 -11.21%
2016 119 2.52%
2017 121 1.65%
2018 114 -7.08%
2019 123 8.13%
2020 175 29.71%
2021 183 4.37%
2022 222 17.57%
2023 228 2.63%
2023 261 12.64%
2024 367 28.69%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

PT Tempo Scan Pacific Tbk Free Cashflow
Year Free Cashflow Growth
2005 97.528.166.954
2006 143.914.798.368 32.23%
2007 210.804.180.478 31.73%
2008 216.841.300.697 2.78%
2009 352.060.963.628 38.41%
2010 467.674.528.806 24.72%
2011 384.806.382.466 -21.54%
2012 424.415.220.760 9.33%
2013 26.695.952.326 -1489.81%
2014 97.952.991.825 72.75%
2015 516.029.313.542 81.02%
2016 103.390.140.969 -399.11%
2017 173.428.160.202 40.38%
2018 -25.086.498.744 791.32%
2019 561.087.624.123 104.47%
2020 534.862.317.217 -4.9%
2021 303.782.866.207 -76.07%
2022 601.158.955.987 49.47%
2023 872.808.106.970 31.12%
2023 320.087.220.571 -172.68%
2024 226.149.865.223 -41.54%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

PT Tempo Scan Pacific Tbk Operating Cashflow
Year Operating Cashflow Growth
2005 297.704.290.027
2006 234.892.877.849 -26.74%
2007 294.712.577.526 20.3%
2008 292.296.080.215 -0.83%
2009 476.589.761.145 38.67%
2010 578.089.303.003 17.56%
2011 587.799.605.916 1.65%
2012 635.028.604.390 7.44%
2013 448.669.480.614 -41.54%
2014 501.514.626.600 10.54%
2015 778.361.981.647 35.57%
2016 491.655.348.447 -58.31%
2017 562.484.172.314 12.59%
2018 441.132.846.384 -27.51%
2019 889.775.270.261 50.42%
2020 982.698.939.026 9.46%
2021 689.652.508.330 -42.49%
2022 1.193.325.533.540 42.21%
2023 1.199.458.669.278 0.51%
2023 432.736.308.055 -177.18%
2024 308.989.615.605 -40.05%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

PT Tempo Scan Pacific Tbk Capital Expenditure
Year Capital Expenditure Growth
2005 200.176.123.073
2006 90.978.079.481 -120.03%
2007 83.908.397.048 -8.43%
2008 75.454.779.518 -11.2%
2009 124.528.797.517 39.41%
2010 110.414.774.197 -12.78%
2011 202.993.223.450 45.61%
2012 210.613.383.630 3.62%
2013 421.973.528.288 50.09%
2014 403.561.634.775 -4.56%
2015 262.332.668.105 -53.84%
2016 388.265.207.478 32.43%
2017 389.056.012.112 0.2%
2018 466.219.345.128 16.55%
2019 328.687.646.138 -41.84%
2020 447.836.621.809 26.61%
2021 385.869.642.123 -16.06%
2022 592.166.577.553 34.84%
2023 326.650.562.308 -81.28%
2023 112.649.087.484 -189.97%
2024 82.839.750.382 -35.98%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

PT Tempo Scan Pacific Tbk Equity
Year Equity Growth
2005 1.873.286.259.655
2006 2.031.932.140.399 7.81%
2007 2.214.765.559.883 8.26%
2008 2.311.124.721.444 4.17%
2009 2.443.455.817.360 5.42%
2010 2.644.733.210.591 7.61%
2011 3.045.935.747.008 13.17%
2012 3.353.156.079.810 9.16%
2013 3.862.951.854.240 13.2%
2014 4.132.338.998.550 6.52%
2015 4.337.140.975.120 4.72%
2016 4.635.273.142.692 6.43%
2017 5.082.008.409.145 8.79%
2018 5.432.848.070.494 6.46%
2019 5.791.035.969.893 6.19%
2020 6.377.235.707.755 9.19%
2021 6.875.303.997.165 7.24%
2022 7.550.757.105.430 8.95%
2023 8.065.636.792.302 6.38%
2023 8.068.498.399.515 0.04%
2024 8.634.851.609.223 6.56%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

PT Tempo Scan Pacific Tbk Assets
Year Assets Growth
2005 2.345.759.617.952
2006 2.479.250.656.231 5.38%
2007 2.773.134.866.559 10.6%
2008 2.967.057.055.450 6.54%
2009 3.263.102.915.008 9.07%
2010 3.589.595.911.220 9.1%
2011 4.250.374.395.321 15.55%
2012 4.632.984.970.719 8.26%
2013 5.407.957.915.805 14.33%
2014 5.592.730.492.960 3.3%
2015 6.284.729.099.203 11.01%
2016 6.585.807.349.438 4.57%
2017 7.434.900.309.021 11.42%
2018 7.869.975.060.326 5.53%
2019 8.372.769.580.743 6.01%
2020 9.104.657.533.366 8.04%
2021 9.644.326.662.784 5.6%
2022 11.328.974.079.150 14.87%
2023 11.315.730.833.410 -0.12%
2023 11.310.522.211.933 -0.05%
2024 12.093.480.385.166 6.47%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

PT Tempo Scan Pacific Tbk Liabilities
Year Liabilities Growth
2005 472.473.358.297
2006 447.318.515.832 -5.62%
2007 558.369.306.676 19.89%
2008 655.932.334.006 14.87%
2009 819.647.097.648 19.97%
2010 944.862.700.629 13.25%
2011 1.204.438.648.313 21.55%
2012 1.279.828.890.909 5.89%
2013 1.545.006.061.565 17.16%
2014 1.460.391.494.410 -5.79%
2015 1.947.588.124.083 25.02%
2016 1.950.534.206.746 0.15%
2017 2.352.891.899.876 17.1%
2018 2.437.126.989.832 3.46%
2019 2.581.733.610.850 5.6%
2020 2.727.421.825.611 5.34%
2021 2.769.022.665.619 1.5%
2022 3.778.216.973.720 26.71%
2023 3.250.094.041.108 -16.25%
2023 3.242.023.812.418 -0.25%
2024 3.458.628.775.943 6.26%

PT Tempo Scan Pacific Tbk Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2973.51
Net Income per Share
289.51
Price to Earning Ratio
9.02x
Price To Sales Ratio
0.88x
POCF Ratio
7.34
PFCF Ratio
9.82
Price to Book Ratio
1.44
EV to Sales
0.64
EV Over EBITDA
4.2
EV to Operating CashFlow
5.33
EV to FreeCashFlow
7.13
Earnings Yield
0.11
FreeCashFlow Yield
0.1
Market Cap
11.771 Bil.
Enterprise Value
8.543 Bil.
Graham Number
3437.69
Graham NetNet
691.32

Income Statement Metrics

Net Income per Share
289.51
Income Quality
1.23
ROE
0.16
Return On Assets
0.11
Return On Capital Employed
0.19
Net Income per EBT
0.7
EBT Per Ebit
1.09
Ebit per Revenue
0.13
Effective Tax Rate
0.23

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.36
Operating Profit Margin
0.13
Pretax Profit Margin
0.14
Net Profit Margin
0.1

Dividends

Dividend Yield
0.05
Dividend Yield %
4.79
Payout Ratio
0.36
Dividend Per Share
125

Operating Metrics

Operating Cashflow per Share
355.42
Free CashFlow per Share
265.71
Capex to Operating CashFlow
0.25
Capex to Revenue
0.03
Capex to Depreciation
1.26
Return on Invested Capital
0.15
Return on Tangible Assets
0.11
Days Sales Outstanding
47.63
Days Payables Outstanding
50.92
Days of Inventory on Hand
85.07
Receivables Turnover
7.66
Payables Turnover
7.17
Inventory Turnover
4.29
Capex per Share
89.72

Balance Sheet

Cash per Share
947,02
Book Value per Share
1.914,66
Tangible Book Value per Share
1914.66
Shareholders Equity per Share
1814.23
Interest Debt per Share
208.69
Debt to Equity
0.11
Debt to Assets
0.07
Net Debt to EBITDA
-1.59
Current Ratio
2.77
Tangible Asset Value
8.635 Bil.
Net Current Asset Value
4.892 Bil.
Invested Capital
8575154099563
Working Capital
5.337 Bil.
Intangibles to Total Assets
0
Average Receivables
1.825 Bil.
Average Payables
1.265 Bil.
Average Inventory
1947229156321.5
Debt to Market Cap
0.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

PT Tempo Scan Pacific Tbk Dividends
Year Dividends Growth
2006 300
2007 25 -1100%
2008 60 58.33%
2009 40 -50%
2010 65 38.46%
2011 40 -62.5%
2012 75 46.67%
2013 75 0%
2014 75 0%
2015 64 -17.19%
2016 50 -28%
2017 50 0%
2018 40 -25%
2019 40 0%
2020 50 20%
2021 80 37.5%
2022 75 -6.67%
2023 150 50%
2024 75 -100%

PT Tempo Scan Pacific Tbk Profile

About PT Tempo Scan Pacific Tbk

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through three segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; provision of warehousing, freight forwarding, advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. The company was founded in 1970 and is headquartered in Jakarta, Indonesia. PT Tempo Scan Pacific Tbk is a subsidiary of PT Bogamulia Nagadi.

CEO
Mr. I Made Dharma Wijaya
Employee
4.530
Address
Tempo Scan Tower
Jakarta, 12950

PT Tempo Scan Pacific Tbk Executives & BODs

PT Tempo Scan Pacific Tbk Executives & BODs
# Name Age
1 Mr. I Made Dharma Wijaya
President Director and MD of Sales & Operation - Distribution Division
70
2 Kartika Chandra Sutantio
Corporate Finance & Treasury Director
70
3 Ms. - Shania
Group General Counsel Director, Corporate Secretary & Director
70
4 Ms. Linda Lukitasari
Research & Development Director and Director
70
5 Nina Muthmainnah
Managing Director of International Business and License Cosmetics
70
6 F. Cisca Dwijani
Managing Director of Prescription Medicine Group
70
7 Mr. Swasta Kusnadi
Head of Internal Audit
70
8 Mr. Galang Putra Ariyanto
Head of Internal Audit of Distribution Division
70

PT Tempo Scan Pacific Tbk Competitors